Overall, the prognosis is poor. The one-year mortality has been reported to be close to 72%.

Outcomes after heart-lung or lung transplant for pulmonary veno-occlusive disease patients are similar to outcomes of other patients with pulmonary arterial hypertension requiring a transplant.